Allianca Saude e Participacoes SA - ALLIAR

Allianca Saude e Participacoes SA - ALLIAR

0.96
BRL
-0.41
(-29.93%)
-8.93EPS
740.28MMarket Cap
Mar 17Next Earn

Total Valuation

BRL

As of December 31, 2025, Allianca Saude e Participacoes SA - ALLIAR carries a market capitalization of 740.28M, placing it among publicly traded companies globally. Its enterprise value stands at 1.40B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap740.28M
Enterprise Value1.40B

Important Dates

Allianca Saude e Participacoes SA - ALLIAR's next confirmed earnings release is scheduled for March 17, 2027.

Earnings Date3/17/2027

Share Statistics

As of December 31, 2025, Allianca Saude e Participacoes SA - ALLIAR has 152.32M shares outstanding.

Shares Outstanding152.32M

Valuation Ratios

These figures are as of December 31, 2025. The price-to-sales ratio is 0.64, and the price-to-book ratio stands at -2.67.

PS Ratio0.64
PB Ratio-2.67
P/TBV Ratio-1.33
P/FCF Ratio6.03
P/OCF Ratio3.69

Enterprise Valuation

These figures are as of December 31, 2025. The EV/Sales ratio of 1.21 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.40B versus a market cap of 740.28M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales1.21

Financial Position

As of December 31, 2025, Allianca Saude e Participacoes SA - ALLIAR maintains a current ratio of 0.28, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -276.40, indicating conservative leverage, while an interest coverage ratio of -7.68 demonstrates limited ability to service its debt obligations.

Current Ratio0.28
Quick Ratio0.03
Debt / Equity-276.40
Debt / EBITDA-0.73
Interest Coverage-7.68

Financial Efficiency

These figures cover the twelve months ended December 31, 2025. Return on assets (ROA) is negative at -58.82, reflecting losses generated across the asset base. Inventory turnover of 89.07 indicates how many times Allianca Saude e Participacoes SA - ALLIAR sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Assets (ROA)-58.82
Inventory Turnover89.07

Taxes

BRL

Over the twelve months ended December 31, 2025, Allianca Saude e Participacoes SA - ALLIAR recorded 84.16M in income tax expense. The company reported a pretax loss of -1.28B and -1.37B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax84.16M

Stock Price Statistics

BRL

As of the close on November 16, 2026, Allianca Saude e Participacoes SA - ALLIAR's stock has declined approximately 81.43% over the past 52 weeks. The 50-day moving average sits at 2.89, while the 200-day moving average is 3.36.

52-Week Price Change-81.43%
50-Day Moving Average2.89
200-Day Moving Average3.36

Income Statement

BRL

Over the twelve months ended December 31, 2025, Allianca Saude e Participacoes SA - ALLIAR generated 1.15B in revenue and converted that into -1.37B in net income, yielding earnings per share of -8.93. EBITDA reached -952.30M, while operating income came in at -1.04B.

Revenue1.15B
Gross Profit239.54M
Operating Income-1.04B
Pretax Income-1.28B
Net Income-1.37B
EBITDA-952.30M
EBIT-1.04B
Earnings Per Share (EPS)-8.93

Balance Sheet

BRL

As of December 31, 2025, Allianca Saude e Participacoes SA - ALLIAR holds 61.40M in cash and equivalents against 697.17M in total debt, resulting in a net debt position of 451.60M. Total book value stands at -277.54M, with working capital of -1.28B providing operational flexibility.

Cash & Cash Equivalents61.40M
Total Debt697.17M
Net Debt451.60M
Equity (Book Value)-277.54M
Book Value Per Share-1.82
Working Capital-1.28B

Cash Flow

BRL

Allianca Saude e Participacoes SA - ALLIAR produced 200.70M in operating cash flow over the twelve months ended December 31, 2025. After subtracting -77.85M in capital expenditures, free cash flow totaled 122.84M - equivalent to 0.81 per share.

Operating Cash Flow200.70M
Capital Expenditures-77.85M
Free Cash Flow122.84M
FCF Per Share0.81

Margins

Over the twelve months ended December 31, 2025, Allianca Saude e Participacoes SA - ALLIAR posted a gross margin of 20.76, reflecting its pricing power and cost economics. The operating margin of -90.34 and net profit margin of -118.94 provide insight into operational efficiency.

Gross Margin20.76
Operating Margin-90.34
Pretax Margin-110.55
Profit Margin-118.94
EBITDA Margin-82.53

Dividends & Yields

BRL

Over the twelve months ended December 31, 2025, Allianca Saude e Participacoes SA - ALLIAR paid dividends of 0.02 per share. The dividend payout ratio of -0.21 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 16.59, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 56.57, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Allianca Saude e Participacoes SA - ALLIAR shareholders.

Dividend Per Share0.02
Payout Ratio-0.21
Shareholder Yield56.57
FCF Yield16.59

Scores

As of December 31, 2025, Allianca Saude e Participacoes SA - ALLIAR has an Altman Z-Score of -4.21, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-4.21